Breakthroughs in Pediatric RSV Therapeutics: A New Era of Neonatal Protection
The landscape of pediatric healthcare is witnessing a significant shift as new preventive measures for Respiratory Syncytial Virus (RSV) take center stage. For decades, RSV has been a leading cause of hospitalization among infants worldwide, often resulting in severe bronchiolitis and pneumonia. However, recent clinical advancements and the introduction of long-acting monoclonal antibodies have...
0 Commenti 0 condivisioni 99 Views 0 Anteprima